Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
03/2007
03/22/2007US20070065488 Food composition having anti-stress action
03/22/2007US20070065445 Novel cyclooxygenase variants and methods of use
03/22/2007US20070065429 Nogo-receptor antagonists for the treatment of conditions involving amyloid plaques
03/22/2007DE102005042828A1 Ausgewählte CGPR-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGPR antagonists, process for their preparation and their use as medicaments
03/22/2007CA2622605A1 Heterocycle compound, and production process and application thereof
03/22/2007CA2622571A1 Methods of modulating neurotrophin-mediated activity
03/22/2007CA2622222A1 Therapeutic pyrrolidines
03/22/2007CA2621983A1 Azafused cyclin dependent kinase inhibitors
03/22/2007CA2621817A1 Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
03/22/2007CA2621408A1 1,2-diarylimidazoles for use as cb1 modulators
03/22/2007CA2621370A1 Salicylate and gentisate salts of a piperazine compound
03/22/2007CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity
03/22/2007CA2621270A1 3-(2-dimethylaminomethyl cyclohexyl) phenol retard formulation
03/22/2007CA2621266A1 Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof
03/22/2007CA2620755A1 Glucuronate salt of a piperazine compound
03/22/2007CA2619419A1 Fused tricyclic mglur1 antagonists as therapeutic agents
03/22/2007CA2619309A1 Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
03/22/2007CA2617394A1 2-aniline-4-aryl substituted thiazole derivatives
03/22/2007CA2616237A1 Methods of treating nervous disorders
03/21/2007EP1764366A2 Thrombin receptor antagonists
03/21/2007EP1764362A1 Biaryl derivatives
03/21/2007EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain
03/21/2007EP1764134A2 Tetrahydroindolone and purine derivatives linked to arylpiperazines
03/21/2007EP1764101A1 Use of a cholinesterase inhibitor for the treatment of dementia and cognitive impairments
03/21/2007EP1764099A2 Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV
03/21/2007EP1764098A1 Diaminoalcohols derivatives for the treatment of Alzheimer, malaria, HIV
03/21/2007EP1764092A2 Selecting compounds for treatment of Alzheimer's disease
03/21/2007EP1764091A2 Improvements in or relating to amphoteric liposomes
03/21/2007EP1763522A1 Pyridin-2-one compounds and their use as modulators of the dopamine d3 receptor
03/21/2007EP1763518A1 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors
03/21/2007EP1763354A2 Use of reboxetine for the treatment of pain
03/21/2007EP1763353A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR
03/21/2007EP1763345A2 Kinase inhibitors for treating cancers
03/21/2007EP1578740B1 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system
03/21/2007EP1487821B1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
03/21/2007EP1479396B1 Agent for controlling circadian rhythm disorder
03/21/2007EP1455782B1 High-concentration stable meloxicam solutions for needle-less injection
03/21/2007EP1451177B1 Substituted 2-pyrrolidine-2-yl-1h-indole derivatives for the treatment of migraine
03/21/2007EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same
03/21/2007EP1397127B1 Solid pharmaceutucal formulations comprising modafinil
03/21/2007EP1365787B1 Use of amino acid anticonvulsants for treatment of pain
03/21/2007EP1330460B1 Benzoxazinone derivatives, their preparation and use
03/21/2007EP1289529B1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
03/21/2007EP1237878B1 4-pyrimidinyl-n-acyl-l-phenylalanines
03/21/2007EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases
03/21/2007EP1216024B1 Formulation for menopausal women
03/21/2007EP1115425B1 Autoantibody inhibitors
03/21/2007EP1049717B1 Antibodies against human il-12
03/21/2007EP1003494B1 (d)-METHADONE, A NONOPIOID ANALGESIC
03/21/2007CN1934256A Decoy nucleic acid to synoviolin gene promoter
03/21/2007CN1934111A Heteroaryl-fused pyrazolo derivatives
03/21/2007CN1934100A Substituted quinazoline or pyridopyrimidine derivative
03/21/2007CN1934099A N-piperidine derivates as CCR3 modulators
03/21/2007CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists
03/21/2007CN1934094A Diaryl-substituted five-membered heterocycle derivative
03/21/2007CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders
03/21/2007CN1934073A Novel crystal of triterpene derivative
03/21/2007CN1933854A Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient
03/21/2007CN1933849A Methods for treating pain and for treating a medication overuse disorder
03/21/2007CN1933845A Algin oligose and derivative thereof and producing method and use thereof
03/21/2007CN1933825A Use of n-(2-aryl-propionyl)-sulfonamides for the treatment of spinal cord injury
03/21/2007CN1933817A Disintegrating tablets comprising licarbazepine
03/21/2007CN1931372A Brain targeting gene transfer and release system and its prepn process
03/21/2007CN1931359A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931358A Orally administered peptides to ameliorate atherosclerosis
03/21/2007CN1931357A Fragrant liquid quitting smoking
03/21/2007CN1931345A Chinese medicine for eliminating drug addiction and its prepn process
03/21/2007CN1931326A Apoplexy treating capsule
03/21/2007CN1931320A Medicinal wine composition and its prepn process
03/21/2007CN1931293A Oil-in-water type nanometer grassleaved sweetflag oil emulsion oral liquid and its prepn process
03/21/2007CN1931276A Headache treating Chinese medicine composition and its prepn process
03/21/2007CN1931270A Sobering up and liver protecting Chinese medicine prepn and its prepn process
03/21/2007CN1931267A Chinese medicine composition with functions of promoting blood circulation to disperse blood clots and activating qi to stop pain and its prepn process
03/21/2007CN1931256A Chinese medicine capsule for eliminating drug addiction and its prepn process
03/21/2007CN1931251A Analgesic medicine composition and its prepn process and application
03/21/2007CN1931219A Gynostemma pentaphylla micro emulsion medicine and its prepn
03/21/2007CN1931177A Application of 20 (S)-protopanoxadiol derivative in preparing depression treating medicine
03/21/2007CN1931153A Medicine composition including venlafaxine for treating depression and relevant diseases
03/21/2007CN1931140A Orally disintegrated galantamine hydrobromide tablet and its prepn process
03/21/2007CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
03/21/2007CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands
03/21/2007CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
03/21/2007CN1305848C 2,3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
03/21/2007CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
03/21/2007CN1305838C Cinnamide derivatives
03/21/2007CN1305529C Use of IL-18 inhibitors for treating or preventing CNS injuries
03/21/2007CN1305523C Spirit relieving drink and its preparation method
03/21/2007CN1305520C Medicinal composition for get rid of opium drug dependence and its preparation method
03/21/2007CN1305518C Chinese medicine for treating paraplegia
03/21/2007CN1305474C Nose cavity administering formulation of nalmefene
03/20/2007US7193108 Phenylpropionic acid derivatives
03/20/2007US7192975 Arylimidazole derivatives, preparation and therapeutic used thereof
03/20/2007US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5)
03/20/2007US7192964 4-oxoimidazolidine-2-spiropiperidine derivatives
03/20/2007US7192963 Janus Kinase 3 inhibitors; organ transplant rejection, xeno transplation, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes, cancer, asthma, atopic dermatitis, autoimmune thyroid disorders, ulcerative colitis, Crohn's disease, Alzheimer's disease, leukemia, and autoimmune diseases
03/20/2007US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment
03/20/2007US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/20/2007US7192950 Psychological disorders; eating disorders; dietetics
03/20/2007US7192940 Ether compounds
03/20/2007US7192733 screening for drugs that inhibit prostaglandin endoperoxidase (PGE) synthase, for use in treatment of inflammation, arthritis, cancer, Alzheimer's disease, in modulating apoptosis, and treating pain
1 ... 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 ... 1833